Mukand [MUKANDLTD] vs Camlin Fine Sciences [CAMLINFINE] Detailed Stock Comparison

Mukand Ltd.

NSE
Loading...

Camlin Fine Sciences Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Mukand Ltd. wins in 14 metrics, Camlin Fine Sciences Ltd. wins in 5 metrics, with 0 ties. Mukand Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Mukand Ltd. Camlin Fine Sciences Ltd. Better
P/E Ratio (TTM) 35.17 18.52 Camlin Fine Sciences Ltd.
Price-to-Book Ratio 2.23 2.25 Mukand Ltd.
Debt-to-Equity Ratio 189.15 78.10 Camlin Fine Sciences Ltd.
PEG Ratio -1.13 0.03 Camlin Fine Sciences Ltd.
EV/EBITDA 15.80 19.32 Mukand Ltd.
Profit Margin (TTM) 1.28% -3.45% Mukand Ltd.
Operating Margin (TTM) 4.25% 1.16% Mukand Ltd.
EBITDA Margin (TTM) 4.25% 1.16% Mukand Ltd.
Return on Equity 7.99% -15.89% Mukand Ltd.
Return on Assets (TTM) 2.14% -6.87% Mukand Ltd.
Free Cash Flow (TTM) $432.30M $-157.24M Mukand Ltd.
Dividend Yield 2.87% N/A N/A
1-Year Return 16.45% -54.74% Mukand Ltd.
Price-to-Sales Ratio (TTM) 0.45 1.16 Mukand Ltd.
Enterprise Value $39.04B $24.48B Mukand Ltd.
EV/Revenue Ratio 0.83 1.38 Mukand Ltd.
Gross Profit Margin (TTM) 24.21% 45.75% Camlin Fine Sciences Ltd.
Revenue per Share (TTM) $327 $95 Mukand Ltd.
Earnings per Share (Diluted) $4.17 $-0.79 Mukand Ltd.
Beta (Stock Volatility) 0.68 0.53 Camlin Fine Sciences Ltd.

Mukand Ltd. vs Camlin Fine Sciences Ltd. Stock Performance Analysis

Loading Price Chart...

MUKANDLTD
CAMLINFINE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mukand Ltd.1.04%-1.12%-3.83%15.40%2.24%-0.64%
Camlin Fine Sciences Ltd.1.40%8.88%10.60%5.26%-13.69%-5.58%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mukand Ltd.16.45%3.13%19.31%239.37%209.62%79.80%
Camlin Fine Sciences Ltd.-54.74%-19.12%-19.83%50.34%50.01%50.01%

Performance & Financial Health Analysis: Mukand Ltd. vs Camlin Fine Sciences Ltd.

MetricMUKANDLTDCAMLINFINE
Market Information
Market Cap i₹20.71B₹23.13B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i225,7101,528,017
90 Day Avg. Volume i176,042906,720
Last Close₹135.62₹138.64
52 Week Range₹111.50 - ₹162.00₹96.21 - ₹333.30
% from 52W High-16.28%-58.40%
All-Time High₹212.80 (Jan 01, 2024)₹333.30 (Jun 26, 2025)
% from All-Time High-36.27%-58.40%
Growth Metrics
Quarterly Revenue Growth0.06%0.06%
Quarterly Earnings Growth-0.31%0.05%
Financial Health
Profit Margin (TTM) i0.01%-0.03%
Operating Margin (TTM) i0.04%0.01%
Return on Equity (TTM) i0.08%-0.16%
Debt to Equity (MRQ) i189.1578.10
Cash & Liquidity
Book Value per Share (MRQ)₹65.90₹47.62
Cash per Share (MRQ)₹1.87₹8.43
Operating Cash Flow (TTM) i₹-395,700,000₹-1,435,453,000
Levered Free Cash Flow (TTM) i₹758.90M₹-1,390,459,000
Dividends
Last 12-Month Dividend Yield i2.87%N/A
Last 12-Month Dividend i₹4.00₹0.00

Valuation & Enterprise Metrics Analysis: Mukand Ltd. vs Camlin Fine Sciences Ltd.

MetricMUKANDLTD (Apr 24, 2026)CAMLINFINE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i35.1718.52
Forward P/E iN/A22.06
PEG Ratio i-1.130.03
Price to Sales (TTM) i0.451.16
Price to Book (MRQ) i2.232.25
Market Capitalization
Market Capitalization i₹20.71B₹23.13B
Enterprise Value i₹39.04B₹24.48B
Enterprise Value Metrics
Enterprise to Revenue i0.831.38
Enterprise to EBITDA i15.8019.32
Risk & Other Metrics
Beta i0.680.53
Book Value per Share (MRQ) i₹65.90₹47.62

Financial Statements Comparison: Mukand Ltd. vs Camlin Fine Sciences Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMUKANDLTD (2025)CAMLINFINE (2025)
Revenue/Sales i48.74B16.36B
Cost of Goods Sold i39.88B8.70B
COGS % of Revenue i81.8%53.2%
Gross Profit i8.86B7.66B
Gross Margin i18.2%46.8%
Research & Development iN/AN/A
Operating Income (EBIT) i2.30B1.56B
Operating Margin i4.7%9.5%
EBITDA i2.93B2.11B
EBITDA Margin i6.0%12.9%
Pre-Tax Income i1.18B494.71M
Pre-Tax Income % of Revenue i2.4%3.0%
Income Tax i424.10M665,000
Income Tax % of Revenue i0.9%0.0%
Net Income (Profit) i758.90M-1.58B
Profit Margin i1.6%-9.7%

Balance Sheet & Liquidity Metrics

MetricMUKANDLTD (2025)CAMLINFINE (2025)
Cash & Equivalents i216.00M1.04B
Total Current Assets i27.07B11.83B
Total Current Assets % of Revenue i55.5%72.4%
Total Current Liabilities i24.18B8.46B
Total Current Liabilities % of Revenue i49.6%51.7%
Long-Term Debt i1.02B2.93B
Long-Term Debt % of Revenue i2.1%17.9%
Total Shareholders Equity i9.50B8.75B
Retained Earnings i5.70B996.35M
Retained Earnings % of Revenue i11.7%6.1%
Property, Plant & Equipment i5.37B35.37M

Cash Flow Statement Comparison

MetricMUKANDLTD (2025)CAMLINFINE (2025)
Operating Cash Flow i-395.70M-1.44B
Operating Cash Flow % of Revenue i-0.8%-8.8%
Capital Expenditures i-1.05B-424.47M
Free Cash Flow i432.30M-157.24M
FCF Margin i0.9%-1.0%
Debt Repayment i0N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMUKANDLTDCAMLINFINE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i144.50M192.09M
Float Shares i29.85M87.72M
% Held by Insiders i77.48%44.11%
% Held by Institutions i1.12%16.91%
% Held by Public i21.40%38.98%

Dividend Analysis & Yield Comparison: Mukand Ltd. vs Camlin Fine Sciences Ltd.

MetricMUKANDLTDCAMLINFINE
Last 12-Month Dividend i₹4.00₹0.00
Last 12-Month Dividend Yield i2.87%N/A
3-Year Avg Annual Dividend i₹2.50₹0.00
3-Year Avg Dividend Yield i1.28%N/A
3-Year Total Dividends i₹7.50₹0.00
Ex-Dividend DateJul 25, 2025N/A